Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-11 1:14 pm Purchase | 13G | BLACK DIAMOND THERAPEUTICS INC BDTX | T. Rowe Price Investment Management Inc. | 6,675,756 12.9% | 2,747,877 (+69.96%) | View |
| 2024-02-14 10:04 am Purchase | 13G | BLACK DIAMOND THERAPEUTICS INC BDTX | T. Rowe Price Investment Management Inc. | 3,927,879 7.6% | 3,927,879 (New Position) | View |
| 2024-02-13 06:05 am Purchase | 13G | BLACK DIAMOND THERAPEUTICS INC BDTX | BB BIOTECH AG | 8,517,839 16.5% | 3,140,000 (+58.39%) | View |
| 2023-11-09 5:24 pm Unchanged | 13D | BLACK DIAMOND THERAPEUTICS INC BDTX | Versant Venture Capital VI L.P. | 4,328,883 8.4% | 0 (Unchanged) | View |
| 2023-02-14 4:14 pm Purchase | 13G | BLACK DIAMOND THERAPEUTICS INC BDTX | BB BIOTECH AG | 5,377,839 14.8% | 1,389,437 (+34.84%) | View |
| 2022-07-08 4:57 pm Sale | 13G | BLACK DIAMOND THERAPEUTICS INC BDTX | BlackRock Inc. BLK | 1,272,112 3.5% | -976,355 (-43.42%) | View |
| 2022-04-14 12:01 pm Purchase | 13G | BLACK DIAMOND THERAPEUTICS INC BDTX | BB BIOTECH AG | 3,988,402 11% | 548,402 (+15.94%) | View |
| 2022-02-11 4:57 pm Purchase | 13G | BLACK DIAMOND THERAPEUTICS INC BDTX | BB BIOTECH AG | 3,440,000 9.5% | 1,540,000 (+81.05%) | View |
| 2022-02-09 3:33 pm Sale | 13G | BLACK DIAMOND THERAPEUTICS INC BDTX | VANGUARD GROUP INC | 1,014,791 2.8% | -831,171 (-45.03%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | BLACK DIAMOND THERAPEUTICS INC BDTX | BlackRock Inc. BLK | 2,248,467 6.2% | 2,248,467 (New Position) | View |
| 2021-02-11 4:58 pm Purchase | 13G | BLACK DIAMOND THERAPEUTICS INC BDTX | BB BIOTECH AG | 1,900,000 5.3% | 1,900,000 (New Position) | View |
| 2021-02-10 10:39 am Purchase | 13G | BLACK DIAMOND THERAPEUTICS INC BDTX | VANGUARD GROUP INC | 1,845,962 5.13% | 1,845,962 (New Position) | View |
| 2020-12-03 4:47 pm Sale | 13D | BLACK DIAMOND THERAPEUTICS INC BDTX | Versant Venture Capital VI L.P. | 4,328,883 12% | -1,031,634 (-19.25%) | View |
| 2020-11-20 5:32 pm Sale | 13D | BLACK DIAMOND THERAPEUTICS INC BDTX | Versant Venture Capital VI L.P. | 5,360,517 14.9% | -980,734 (-15.47%) | View |
| 2020-09-25 4:37 pm Sale | 13D | BLACK DIAMOND THERAPEUTICS INC BDTX | Versant Venture Capital VI L.P. | 6,341,251 17.7% | -457,424 (-6.73%) | View |
| 2020-08-21 4:19 pm Sale | 13D | BLACK DIAMOND THERAPEUTICS INC BDTX | Versant Venture Capital VI L.P. | 6,798,675 18.9% | -669,608 (-8.97%) | View |
| 2020-02-13 5:23 pm Purchase | 13D | BLACK DIAMOND THERAPEUTICS INC BDTX | Versant Venture Capital VI L.P. | 7,468,283 20.8% | 7,468,283 (New Position) | View |
| 2020-02-13 3:06 pm Purchase | 13G | BLACK DIAMOND THERAPEUTICS INC BDTX | Boxer Capital LLC | 2,014,858 5.6% | 2,014,858 (New Position) | View |
| 2020-02-13 10:51 am Purchase | 13D | BLACK DIAMOND THERAPEUTICS INC BDTX | New Enterprise Associates 16 L.P. | 3,448,757 9.6% | 3,448,757 (New Position) | View |
| 2020-02-05 5:21 pm Purchase | 13D | BLACK DIAMOND THERAPEUTICS INC BDTX | RA CAPITAL MANAGEMENT L.P. | 2,589,904 7.2% | 2,589,904 (New Position) | View |